Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.51 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5706504 | 0.84 | CETP (0.71) | CETPALDH1A1POLBTSHRKMT2A | |
| SCHEMBL1274654 | 0.83 | L3MBTL1 (0.65) | CETPALDH1A1MAPTPOLBHTT | |
| SCHEMBL11384145 | 0.83 | POLB (0.51) | ALDH1A1MAPTGAAPOLBHDAC3 | |
| SCHEMBL27776504 | 0.82 | CETP (0.51) | CETPALDH1A1POLBHDAC3HDAC4 | |
| SCHEMBL10072798 | 0.81 | CETP (0.54) | CETPALDH1A1MAPTPOLBTSHR | |
| SCHEMBL10517984 | 0.80 | ALDH1A1 (0.51) | CETPALDH1A1MAPTKMT2AMEN1 | |
| SCHEMBL8674755 | 0.80 | CETP (0.50) | CETPMAPTPOLBTSHRHTT | |
| SCHEMBL9717979 | 0.80 | HTT (0.72) | ALDH1A1MAPTGAAPOLBHDAC3 | |
| SCHEMBL29580443 | 0.80 | HTT (0.72) | ALDH1A1MAPTGAAPOLBHDAC3 | |
| SCHEMBL2349955 | 0.80 | MAPT (0.61) | ALDH1A1MAPTGAAPOLBHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7847108-B2 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER CROPSCIENCE AG (DE) | 2010-12-07 | — | — | US | disclosed |
| US-7847108-B2 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER CROPSCIENCE AG (DE) | 2010-12-07 | — | — | US | disclosed |
| US-7847108-B2 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER CROPSCIENCE AG (DE) | 2010-12-07 | — | — | US | disclosed |
| EP-1599460-B1 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AG (DE) | 2007-11-07 | — | — | EP | disclosed |
| EP-1599460-B1 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AG (DE) | 2007-11-07 | — | — | EP | disclosed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-1599460-A2 | OXATHIIN CARBOXAMIDE | Bayer CropScience Aktiengesellschaft (DE) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004072023-A2 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | Q6ZSR9, PFAS, NIT2 | CETP 4669/4885ALDH1A1 1804/4885MAPT 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.